Triptorelin Acetate is a peptide formulation for injection that was initially developed and continues to be used mainly in the treatment of advanced metastatic prostate cancer. Additional indications developed subsequently include the treatment of uterine fibroids (a benign tumour of muscle tissues in the uterus), endometriosis (proliferation of endometrial tissue, the mucous membrane that lines the uterine wall outside the reproductive tract) prior to surgery or when surgery is not deemed appropriate, as well as early onset puberty and female infertility (in vitro fertilisation).
The global production of triptorelin acetate is about 2770 k units in 2015, the production region is mainly concentrated in Europe, the biggest three countries are France, Germany and Ireland. The top two companies are Ipsen and Ferring, they occupies about 95% market shares;
Although the production region is very concentration, the consumption region is very dispersion, in 2015, the largest consumption Europe is about 38%, the North America consumes about 12% market share, China occupies about 9% market share, Japan occupies about 8.29% market share.
The production and consumption region is different, the production region is mainly concentrated in Europe, the consumption region is dispersion in all over the world; the countries which do not include in the Europe mainly depends on import.
According to this study, over the next five years the Triptorelin Acetate market will register a 4.7% CAGR in terms of revenue, the global market size will reach USD 600 million by 2024, from USD 460 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Triptorelin Acetate business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Triptorelin Acetate market by product type, application, key manufacturers and key regions and countries.
This study considers the Triptorelin Acetate value and volume generated from the sales of the following segments-
Segmentation by product type- breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
0.1 mg
3 mg
11.25 mg
Segmentation by application- breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Male Disease
Female Disease
This report also splits the market by region- Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report- Breakdown data in in Chapter 3.
Ipsen
Ferring
Chengdu Tiantaishan
TECNOFARMA
Changchun Gensci
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Triptorelin Acetate consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Triptorelin Acetate market by identifying its various subsegments.
Focuses on the key global Triptorelin Acetate manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Triptorelin Acetate with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Triptorelin Acetate submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
